{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:40:33Z","timestamp":1792410033222,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["2018-ER6901-02"],"award-info":[{"award-number":["2018-ER6901-02"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>GNAO1 encephalopathy is a rare neurodevelopmental disorder characterized by distinct movement presentations and early onset epileptic encephalopathy. Here, we report the in-depth phenotyping of genetically confirmed patients with GNAO1 encephalopathy, focusing on movement presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six patients who participated in Korean Undiagnosed Disease Program were diagnosed to have pathogenic or likely pathogenic variants in\n                      <jats:italic>GNAO1<\/jats:italic>\n                      using whole exome sequencing. All medical records and personal video clips were analyzed with a literature review. Three of the 6 patients were male. Median follow-up duration was 41\u00a0months (range 7\u201378\u00a0months) and age at last examination was 7.4\u00a0years (range 3.3\u201316.9\u00a0years). Initial complaints were hypotonia or developmental delay in 5 and right-hand clumsiness in 1 patient, which were noticed at median age of 3\u00a0months (range 0\u201375\u00a0months). All patients showed global developmental delay and 4 had severely retarded development. Five patients (5\/6, 83.3%) had many different movement symptoms with various onset and progression. The symptoms included stereotyped hands movement, non-epileptic myoclonus, dyskinesia, dystonia and choreoathetosis. Whole exome sequencing identified 6 different variants in\n                      <jats:italic>GNAO1<\/jats:italic>\n                      . Three were novel de novo variants and atypical presentation was noted in a patient. One variant turned out to be inherited from patient\u2019s mother who had mosaic variant. Distinct and characteristics movement phenotypes in patients with variant p.Glu246Lys and p.Arg209His were elucidated by in-depth phenotyping and literature review.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We reported 6 patients with GNAO1 encephalopathy showing an extremely diverse clinical spectrum on video. Some characteristic movement features identified by careful inspection may also provide important diagnostic insight and practice guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01594-3","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T06:23:52Z","timestamp":1607495032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Soo Yeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YoungKyu","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soojin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Song","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Chan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-0138","authenticated-orcid":false,"given":"Jong-Hee","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"issue":"3","key":"1594_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajhg.2013.07.014","volume":"93","author":"K Nakamura","year":"2013","unstructured":"Nakamura K, Kodera H, Akita T, Shiina M, Kato M, Hoshino H, et al. De Novo mutations in GNAO1, encoding a Galphao subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet. 2013;93(3):496\u2013505.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1594_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/0883073815587945","volume":"31","author":"N Kulkarni","year":"2016","unstructured":"Kulkarni N, Tang S, Bhardwaj R, Bernes S, Grebe TA. Progressive movement disorder in brothers carrying a GNAO1 mutation responsive to deep brain stimulation. J Child Neurol. 2016;31(2):211\u20134.","journal-title":"J Child Neurol"},{"key":"1594_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pediatrneurol.2016.03.011","volume":"60","author":"P Gawlinski","year":"2016","unstructured":"Gawlinski P, Posmyk R, Gambin T, Sielicka D, Chorazy M, Nowakowska B, et al. PEHO syndrome may represent phenotypic expansion at the severe end of the early-onset encephalopathies. Pediatr Neurol. 2016;60:83\u20137.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"1594_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1055\/s-0037-1603977","volume":"48","author":"DC Schorling","year":"2017","unstructured":"Schorling DC, Dietel T, Evers C, Hinderhofer K, Korinthenberg R, Ezzo D, et al. Expanding phenotype of de novo mutations in GNAO1: four new cases and review of literature. Neuropediatrics. 2017;48(5):371\u20137.","journal-title":"Neuropediatrics"},{"issue":"1","key":"1594_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1684\/epd.2017.0888","volume":"19","author":"R Arya","year":"2017","unstructured":"Arya R, Spaeth C, Gilbert DL, Leach JL, Holland KD. GNAO1-associated epileptic encephalopathy and movement disorders: c.607G>A variant represents a probable mutation hotspot with a distinct phenotype. Epileptic Disord. 2017;19(1):67\u201375.","journal-title":"Epileptic Disord."},{"key":"1594_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pediatrneurol.2016.02.018","volume":"59","author":"AL Ananth","year":"2016","unstructured":"Ananth AL, Robichaux-Viehoever A, Kim YM, Hanson-Kahn A, Cox R, Enns GM, et al. Clinical course of six children with GNAO1 mutations causing a severe and distinctive movement disorder. Pediatr Neurol. 2016;59:81\u20134.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"1594_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ejhg.2015.92","volume":"24","author":"H Saitsu","year":"2016","unstructured":"Saitsu H, Fukai R, Ben-Zeev B, Sakai Y, Mimaki M, Okamoto N, et al. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay. Eur J Hum Genet. 2016;24(1):129\u201334.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"1594_CR8","doi-asserted-by":"crossref","first-page":"2329048X1558371","DOI":"10.1177\/2329048X15583717","volume":"2","author":"I Talvik","year":"2015","unstructured":"Talvik I, Moller RS, Vaher M, Vaher U, Larsen LH, Dahl HA, et al. Clinical phenotype of de novo GNAO1 mutation: case report and review of literature. Child Neurol Open. 2015;2(2):2329048X15583717.","journal-title":"Child Neurol Open."},{"issue":"2","key":"1594_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/jnnp-2017-315653","volume":"89","author":"M Waak","year":"2018","unstructured":"Waak M, Mohammad SS, Coman D, Sinclair K, Copeland L, Silburn P, et al. GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS. J Neurol Neurosurg Psychiatry. 2018;89(2):221\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"1594_CR10","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1177\/0883073816666474","volume":"31","author":"LA Menke","year":"2016","unstructured":"Menke LA, Engelen M, Alders M, Odekerken VJ, Baas F, Cobben JM. Recurrent GNAO1 mutations associated with developmental delay and a movement disorder. J Child Neurol. 2016;31(14):1598\u2013601.","journal-title":"J Child Neurol"},{"issue":"8","key":"1594_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1212\/WNL.0000000000004262","volume":"89","author":"H Feng","year":"2017","unstructured":"Feng H, Sjogren B, Karaj B, Shaw V, Gezer A, Neubig RR. Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations. Neurology. 2017;89(8):762\u201370.","journal-title":"Neurology"},{"key":"1594_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nbd.2018.05.005","volume":"116","author":"H Feng","year":"2018","unstructured":"Feng H, Khalil S, Neubig RR, Sidiropoulos C. A mechanistic review on GNAO1-associated movement disorder. Neurobiol Dis. 2018;116:131\u201341.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1594_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13023-019-1041-5","volume":"14","author":"SY Kim","year":"2019","unstructured":"Kim SY, Lim BC, Lee JS, Kim WJ, Kim H, Ko JM, et al. The Korean undiagnosed diseases program: lessons from a one-year pilot project. Orphanet J Rare Dis. 2019;14(1):68.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1594_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"4","key":"1594_CR15","first-page":"546","volume":"48","author":"S Kim","year":"2018","unstructured":"Kim S, Han J, Kim HA, Lim BC, Seo JE, Choi M, et al. Neuropathy, ataxia, retinitis pigmentosa-like phenotype associated with a mitochondrial G8363A mutation in a family. Ann Clin Lab Sci. 2018;48(4):546\u20138.","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"1594_CR16","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1212\/NXG.0000000000000143","volume":"3","author":"FR Danti","year":"2017","unstructured":"Danti FR, Galosi S, Romani M, Montomoli M, Carss KJ, Raymond FL, et al. GNAO1 encephalopathy: broadening the phenotype and evaluating treatment and outcome. Neurol Genet. 2017;3(2):e143.","journal-title":"Neurol Genet"},{"key":"1594_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.ajhg.2019.04.011","volume":"104","author":"D Monies","year":"2019","unstructured":"Monies D, Abouelhoda M, Assoum M, Moghrabi N, Rafiullah R, Almontashiri N, et al. Lessons learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population. Am J Hum Genet. 2019;104:1182\u2013201.","journal-title":"Am J Hum Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01594-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01594-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T06:55:56Z","timestamp":1607496956000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01594-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1594"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01594-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-60924\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-60924\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"17 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was in accordance with the tenets of Declaration of Helsinki and was approved by the Institutional Review Board of Seoul National University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Three families agreed to report the case with patients\u2019 video clips. Independent written informed consents were obtained from the parents. We greatly appreciate the patients and their families for providing their videos and agreeing to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest or financial relationship to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}